SCHEMBL25455288

SCHEMBL25455288

CN1C[C@@H]2CN(C(C)(C)C)C[C@]2(C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19419598 1.00
SCHEMBL27117053 0.91 ATM (0.33)
SCHEMBL27117028 0.91 ATM (0.33)
SCHEMBL20320096 0.82 SLC6A4 (0.34)
SCHEMBL18685394 0.82 SLC6A4 (0.34)
SCHEMBL21391958 0.78 ATM (0.31)
SCHEMBL16625645 0.78 ATM (0.31)
SCHEMBL18120030 0.78 ATM (0.31)
SCHEMBL23773733 0.78 ATM (0.31)
SCHEMBL22752551 0.75 SIGMAR1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150975-A1 COMPOUNDS USED AS KINASE INHIBITORS AND APPLICATION THEREOF TYK MEDICINES (ZHENGZHOU), INC. (CN) 2023-05-18 US disclosed
US-11648254-B2 Substituted pyrido[2,3-d]pyrimidines as inhibitors of Ras pathway signaling KUMQUAT BIOSCIENCES INC. (US) 2023-05-16 US disclosed